Exploring groundbreaking advances in cancer drug discovery from the British Association for Cancer Research meeting, including precision medicine, AI, and immunotherapy.
Explore how German pharmaceutical companies Bayer, Hoechst, Schering AG, and E. Merck transformed drug discovery through biotechnology in the 20th century.
Exploring how computational software is revolutionizing drug discovery and medicinal chemistry through advanced molecular modeling and AI.
Explore how synthetic biology is revolutionizing drug discovery through engineered biological systems, living factories, and intelligent therapeutics.
Exploring the untapped potential of endophytes - microbial symbionts that produce bioactive compounds with antimicrobial, anticancer, and neuroprotective properties.
Breakthrough methods for straightforward synthesis of N-trifluoromethyl amides, carbamates, thiocarbamates and ureas in drug discovery and materials science.
Explore how physician-scientist Jay Bradner pioneered open-source drug discovery by sharing breakthrough cancer molecules, accelerating treatments worldwide.
Exploring how chemical genomics is revolutionizing drug discovery and disease treatment through systematic gene-chemical interaction mapping.
Exploring the past, present and future of chemogenomics - the discipline mapping interactions between small molecules and biological targets to accelerate drug discovery.
Exploring how ancient plant compounds called chalcones are being transformed into next-generation drugs to combat antibiotic resistance and cancer.